U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size & Outlook
U.S. biotechnology and pharmaceutical services outsourcing market, 2018-2030 (US$M)
Related Markets
U.S. biotechnology and pharmaceutical services outsourcing market highlights
- The U.S. biotechnology and pharmaceutical services outsourcing market generated a revenue of USD 10,270.6 million in 2023 and is expected to reach USD 14,300.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, consulting was the largest revenue generating services in 2023.
- Product Design & Development is the most lucrative services segment registering the fastest growth during the forecast period.
Biotechnology and pharmaceutical services outsourcing market data book summary
| Market revenue in 2023 | USD 10,270.6 million |
| Market revenue in 2030 | USD 14,300.3 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Consulting |
| Fastest growing segment | Product Design & Development |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
| Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
Other key industry trends
- In terms of revenue, U.S. accounted for 22.3% of the global biotechnology and pharmaceutical services outsourcing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biotechnology and pharmaceutical services outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,802.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology And Pharmaceutical Services Outsourcing Market Scope
Biotechnology And Pharmaceutical Services Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. biotechnology and pharmaceutical services outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 47.83% in 2024. Horizon Databook has segmented the U.S. biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
Pharmaceutical & biotechnology companies are increasingly outsourcing their development & manufacturing activities to CROs, CMOs, & CDMOs, minimizing product lifecycle costs, accelerating time-to-market, and accessing specialized expertise.
In addition, several pharmaceutical & biotechnology companies outsource part of their regulatory functions to meet the evolving regulation requirements, risk mitigations, and quality assurance, contributing to market growth.
Reasons to subscribe to U.S. biotechnology and pharmaceutical services outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biotechnology and pharmaceutical services outsourcing market databook
-
Our clientele includes a mix of biotechnology and pharmaceutical services outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biotechnology and pharmaceutical services outsourcing market size, by services, 2018-2030 (US$M)
U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
